Surmodics Sees FY24 Adj. EPS $(0.64)-$(0.47) Vs $(0.94) Est.; Revenue $122M-$124M Vs $119.644M Est.
Portfolio Pulse from Benzinga Newsdesk
Surmodics provided its FY24 earnings and revenue guidance, expecting an adjusted EPS between $(0.64) and $(0.47), which is an improvement over the estimated $(0.94). The company also forecasts revenue to be between $122M and $124M, surpassing the estimated $119.644M.
May 01, 2024 | 11:05 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Surmodics expects FY24 adjusted EPS to be better than the estimated $(0.94), with a range of $(0.64) to $(0.47), and forecasts revenue between $122M and $124M, exceeding the $119.644M estimate.
The positive guidance from Surmodics, indicating an improvement in both earnings per share and revenue over the estimates, is likely to be viewed favorably by investors. This suggests operational efficiency and potential growth, leading to a positive short-term impact on the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100